Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
24.9% overvalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
21
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
0.8% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
9
users have commented on this narrative
25
users have followed this narrative
10 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
5.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
45.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Krystal Biotech
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Global Expansion And Clinical Readouts Will Unlock New Markets
Key Takeaways International launches and broad pipeline expansion are set to diversify revenue streams and enhance market presence beyond a single product. Manufacturing efficiencies and favorable global healthcare trends are likely to increase profitability and support sustained premium pricing.
View narrative
US$205.50
FV
29.1% undervalued
intrinsic discount
33.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
1 day ago
author updated this narrative
Noble
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Ultra-deepwater Drilling Will Rebound With Brazilian And West African Pipelines
Key Takeaways Sustained global demand for hydrocarbons, large offshore project pipelines, and sector consolidation are expected to drive higher rig utilization, boost revenue visibility, and strengthen margins. Fleet modernization, operational efficiencies, and diversification into energy transition projects are set to enhance market opportunities, reduce earnings volatility, and improve free cash flow.
View narrative
US$34.20
FV
21.9% undervalued
intrinsic discount
2.12%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
65
users have followed this narrative
1 day ago
author updated this narrative
PVH
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Focusing On Calvin Klein And Tommy Hilfiger Will Create Opportunities
Key Takeaways Streamlined operations focusing on core brands are expected to increase revenue growth, improve margins, and enhance overall earnings. Strategic changes in sales channels and innovative marketing campaigns are driving increased consumer engagement and profitability.
View narrative
US$91.21
FV
16.3% undervalued
intrinsic discount
2.47%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
1 day ago
author updated this narrative
OneMain Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Digitization Trends Will Reshape Consumer Lending And Debt Consolidation
Key Takeaways Expansion into debt consolidation and auto finance, paired with digital platform investment, strengthens market reach and supports revenue growth. Improved credit analytics and focus on high-quality loans are reducing risk, while strong shareholder returns attract yield-oriented investors.
View narrative
US$65.21
FV
12.1% undervalued
intrinsic discount
34.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
27
users have followed this narrative
1 day ago
author updated this narrative
Rithm Capital
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Robust US Housing And Technology Will Unlock Diversified Markets
Key Takeaways Expansion into real estate equity, rentals, and private capital diversifies revenue sources and reduces cyclicality risk. Strong technology investment and flexible capital allocation support enhanced efficiency, profitability, and long-term growth resilience.
View narrative
US$14.20
FV
14.1% undervalued
intrinsic discount
19.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
44
users have followed this narrative
1 day ago
author updated this narrative
Frontline
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Modern ECO-Compliant Fleet Will Capture Increased Demand Amid Geopolitical Shifts
Key Takeaways Frontline's younger, ECO-compliant fleet is well-positioned to capitalize on increased demand from geopolitical developments, potentially boosting net margins via lower operational costs. With strong liquidity and no major debt maturity until later years, Frontline could enhance earnings and shareholder returns amidst geopolitical trade shifts.
View narrative
US$24.01
FV
15.4% undervalued
intrinsic discount
-11.03%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
32
users have followed this narrative
1 day ago
author updated this narrative
Murphy Oil
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
Offshore Exploration And Cost Reductions Will Sustain Future Strength
Key Takeaways Expanded international exploration and efficient core asset operations position the company for enhanced production rates and improved earnings resiliency. Structural cost reductions and prudent capital allocation support strong cash flows and shareholder returns amid ongoing industry consolidation.
View narrative
US$27.67
FV
18.3% undervalued
intrinsic discount
3.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
1 day ago
author updated this narrative
TransMedics Group
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Organ Transplant Demand And International Expansion Will Unlock Future Opportunities
Key Takeaways Rising global demand for organ transplants and healthcare modernization support broader adoption and revenue growth for TransMedics' OCS platform. Expansion into new organs, next-gen products, and recurring service offerings increase market potential and support stronger margins.
View narrative
US$142.29
FV
16.5% undervalued
intrinsic discount
19.81%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
51
users have followed this narrative
1 day ago
author updated this narrative
ExlService Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Digital Transformation And AI Expansion Will Open Global Markets
Key Takeaways Accelerated AI adoption and expansion into new sectors are diversifying revenue streams and supporting stable, long-term growth for ExlService. Deep domain expertise and focus on proprietary data platforms strengthen competitive advantages, boosting higher-margin service offerings and protecting net margins.
View narrative
US$54.71
FV
20.2% undervalued
intrinsic discount
10.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
1 day ago
author updated this narrative
Value any company in seconds
Popular companies